Deciphering the functional role of recurrent PPP2R1A mutations on endometrial metastasis
破译PPP2R1A复发突变对子宫内膜转移的功能作用
基本信息
- 批准号:10601651
- 负责人:
- 金额:$ 4.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalBiogenesisCRISPR/Cas technologyCancer Cell GrowthCancer cell lineCarcinomaCell LineCell secretionCellsCessation of lifeCommunicationComplementComplexCoupledDataDevelopmentDiagnosisDiseaseDisease ProgressionDistantDominant-Negative MutationDose LimitingEndometrialFamilyGenesGenetic TranscriptionGreater sac of peritoneumHeterozygoteHoloenzymesImmunocompromised HostImpairmentIn VitroInjectionsInvadedInvestigationKnock-inLigandsLinkLuciferasesMalignant Epithelial CellMalignant NeoplasmsMediatingModelingMolecularMusMutationNatureNeoplasm MetastasisNodulePathway interactionsPatientsPhenotypePhosphoric Monoester HydrolasesPhosphorylationProcessProtein SubunitsProtein phosphataseProteinsRecurrenceRegulationRoleSerineSerousSignal PathwaySignal TransductionSiteTestingThreonineTransfectionTransforming Growth Factor betaTumor PromotionTumor SubtypeTumor Suppressor ProteinsTumorigenicityUnited StatesUterine CancerUterine Corpus CarcinosarcomaUterine NeoplasmsUterusWNT Signaling PathwayWorkXenograft Modelbeta catenincancer cellcancer typedisorder subtypeeffective therapyenhancing factorgain of functionin vivointraperitonealleiomyosarcomamutantneoplastic cellneutralizing antibodynew therapeutic targetnotch proteinoverexpressionpermissivenessscaffoldsmall hairpin RNAtumortumor initiationtumor microenvironmenttumorigenesistumorigenic
项目摘要
Project Summary: Uterine serous carcinomas (USC), uterine carcinosarcomas (UCS), and leiomyosarcomas
represent the most aggressive subtypes of uterine cancer and account for a disproportionate number of uterine
cancer related deaths in the United States. The lethality of these high-grade uterine cancers is largely due to the
propensity of these cancers to disseminate and metastasize, leaving patients with a lack of effective treatment
options. Despite this, the molecular drivers of the metastatic potential of these disease subtypes remain
incompletely understood.
Previous work by our group and others have identified a recurrent mutational hotspot within the gene
encoding for the A scaffolding subunit of the protein phosphatase 2A (PP2A), PPP2R1A. These mutations,
P179R and S256F, occur exclusively within these high-grade subtypes of uterine cancer and are not found in
any other cancer type. Protein phosphatase 2A (PP2A), is a family of serine/threonine phosphatases, where the
active heterotrimeric form is comprised of the catalytic (C) subunit, the scaffolding (A) subunit, and a substrate
directing regulatory (B) subunit. In aggregate, PP2A is considered a tumor suppressor protein, but certain
heterotrimers have tumor promoting roles. We have shown that these mutations contribute to uterine cancer
tumorigenesis by modulating PP2A function in a manner that impairs the formation of tumor suppressive
heterotrimers, while leaving tumor promoting heterotrimeric complexes intact.
My preliminary data show that the PP2A P179R and S256F mutations enhance tumor initiating capacity,
and the ability to form 3D tumor spheres in vitro. Importantly, uterine cancer cells expressing these mutations
also form intraperitoneal nodules at an increased rate in vivo, suggesting that these mutations may enhance the
establishment of new tumor formation in the peritoneal cavity. Conditioned media from the mutant expressing
uterine cancer cells promoted tumor sphere formation of WT expressing uterine cancer cell growth, indicating
that the mutant cells may create a more permissive tumor microenvironment for tumor formation. Preliminary
data suggests that the mutant cells have increased -catenin phosphorylation and WNT ligand expression.
The working hypothesis of this proposal is that the recurrent mutants, P179R and S256F, enhance uterine
cancer metastasis through increased WNT signaling and secretion of WNT ligands. To test this hypothesis, we
will develop PP2A A knock-in xenograft models to determine how these recurrent mutants contribute to
enhanced metastasis in vivo (Specific Aim 1). Second, mechanistic studies will explore the secreted factors from
the mutant uterine cancer cells, exploring WNT ligands, coupled with secretome analysis. These studies will also
explore the link between loss of PP2A and WNT mediated EMT (Specific Aim 2). This proposal aims to decipher
the functional role of recurrent PP2A A𝛼 mutations on uterine cancer metastasis, which may identify a new
therapeutic target(s) of high-grade uterine cancers.
项目概述:子宫浆液性癌(USC)、子宫癌肉瘤(USC)和子宫肌肉瘤
代表最具侵袭性的子宫癌亚型,在子宫癌中所占比例不成比例
美国与癌症相关的死亡人数。这些高级别子宫癌的致命性在很大程度上是由于
这些癌症有扩散和转移的倾向,使患者缺乏有效的治疗
选择。尽管如此,这些疾病亚型转移潜能的分子驱动因素仍然存在。
不完全理解。
我们小组和其他人之前的工作已经确定了该基因内的一个反复突变的热点
编码蛋白磷酸酶2A(PP2A)的A支架亚基,PPP2R1A。这些突变,
P179R和S256F仅发生在这些高级别子宫癌亚型中,而在
任何其他癌症类型。蛋白磷酸酶2A(PP2A)是一个丝氨酸/苏氨酸磷酸酶家族,其中
活性杂三聚体由催化(C)亚基、支架(A)亚基和底物组成
指导调节(B)亚单位。总体而言,PP2A被认为是一种肿瘤抑制蛋白,但某些
异源三聚体具有促癌作用。我们已经证明这些突变与子宫癌有关。
以抑制肿瘤形成的方式调节PP2A功能的肿瘤发生
异三聚体,同时保持促进肿瘤的异三聚体复合体完好无损。
我的初步数据显示,PP2A P179R和S256F突变增强了肿瘤的启动能力,
以及在体外形成3D肿瘤球体的能力。重要的是,表达这些突变的子宫癌细胞
在体内也以增加的速度形成腹膜结节,这表明这些突变可能增强了
建立腹膜腔内新的肿瘤形成模型。突变表达的条件培养液
子宫癌细胞促进肿瘤球体形成表达子宫癌细胞生长的WT,提示
突变细胞可能会为肿瘤的形成创造更宽松的肿瘤微环境。初步
数据表明,突变细胞增加了-连环蛋白的磷酸化和WNT配体的表达。
这一建议的工作假设是,反复出现的突变体P179R和S256F增强了子宫
肿瘤转移通过增加WNT信号和分泌WNT配体来实现。为了检验这一假设,我们
将开发PP2A敲入异种移植模型,以确定这些反复突变是如何促进
促进体内转移(特定目标1)。第二,机械论研究将探索
突变的子宫癌细胞,探索WNT配体,结合分泌组分析。这些研究还将
探讨PP2A缺失与WNT介导的EMT之间的联系(特异性目标2)。这项提案旨在破译
复发的PP2A𝛼突变在子宫癌转移中的功能作用
高级别子宫癌的治疗靶点(S)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Terrance James Haanen其他文献
Terrance James Haanen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
UMSC-Exo通过调控Ribosome biogenesis诱导心肌再生的策略及机制研究
- 批准号:82370264
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
活体动物线粒体biogenesis、fission及fusion对肝脏再生中能量供应影响机制的研究
- 批准号:81470878
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
相似海外基金
Biogenesis of the mitochondrial beta-barrel membrane protein at the intermembrane space.
膜间空间线粒体β-桶膜蛋白的生物发生。
- 批准号:
24K18071 - 财政年份:2024
- 资助金额:
$ 4.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
白血病幹細胞におけるRibosomal biogenesisの解明と治療戦略の構築
白血病干细胞核糖体生物发生的阐明和治疗策略的开发
- 批准号:
24H00639 - 财政年份:2024
- 资助金额:
$ 4.08万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
New mechanisms regulating the biogenesis of extracellular vesicles
调节细胞外囊泡生物发生的新机制
- 批准号:
DP240101427 - 财政年份:2024
- 资助金额:
$ 4.08万 - 项目类别:
Discovery Projects
DEL-1 Promotes Biogenesis of Mineralizing Extracellular Vesicles by Mediating Intracellular Calcium Signaling
DEL-1 通过介导细胞内钙信号传导促进矿化细胞外囊泡的生物合成
- 批准号:
24K19876 - 财政年份:2024
- 资助金额:
$ 4.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
MFB: Characterization of the Biogenesis, Uptake, and Cellular Response to the Ribonucleoprotein Cargoes of Extracellular Vesicles using EV-CLASP
MFB:使用 EV-CLASP 表征细胞外囊泡核糖核蛋白货物的生物合成、摄取和细胞反应
- 批准号:
2330665 - 财政年份:2024
- 资助金额:
$ 4.08万 - 项目类别:
Standard Grant
Mechanisms of PIKII-dependent transport during secretory granule biogenesis
分泌颗粒生物发生过程中 PIKII 依赖性运输的机制
- 批准号:
490594 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Operating Grants
MITOCHONDRIA REDOX BIOGENESIS AND METABOLIC RAMAN IMAGING IN INSULIN SIGNALLING
胰岛素信号传导中的线粒体氧化还原生物发生和代谢拉曼成像
- 批准号:
2883511 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Studentship
Changes in structure and biogenesis of Gram-negative envelope following a polymyxin challenge
多粘菌素攻击后革兰氏阴性包膜的结构和生物发生的变化
- 批准号:
BB/X000370/1 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别:
Research Grant
Molecular Mechanisms of Mitochondrial Biogenesis
线粒体生物发生的分子机制
- 批准号:
10735778 - 财政年份:2023
- 资助金额:
$ 4.08万 - 项目类别: